These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 3390924

  • 21. [Functioning biological activity of mean mineralized sodium bicarbonate in water from the "Pitoniakówka" source in Szczawnica, designed for health resort potable cures].
    Drobnik M, Latour T.
    Rocz Panstw Zakl Hig; 2001; 52(1):41-7. PubMed ID: 11452742
    [Abstract] [Full Text] [Related]

  • 22. The emerging problem of plasma lipid changes during antihypertensive therapy.
    Johnson BF.
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S213-21. PubMed ID: 6177959
    [Abstract] [Full Text] [Related]

  • 23. Efficacy and tolerability of lovastatin in hypercholesterolemia in patients with systemic hypertension.
    D'Agostino RB, Kannel WB, Stepanians MN, D'Agostino LC.
    Am J Cardiol; 1993 Jan 01; 71(1):82-7. PubMed ID: 8093585
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. The effect of nifedipine on plasma lipids in patients with essential hypertension.
    Lehtonen A, Tanskanen A, Lehto H, Jarvensiven P.
    Int J Clin Pharmacol Ther Toxicol; 1986 Jul 01; 24(7):357-8. PubMed ID: 3460970
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Can guava fruit intake decrease blood pressure and blood lipids?
    Singh RB, Rastogi SS, Singh NK, Ghosh S, Gupta S, Niaz MA.
    J Hum Hypertens; 1993 Feb 01; 7(1):33-8. PubMed ID: 8383769
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Antihypertensive therapy and the risk of coronary heart disease.
    Ames RP, Hill P.
    J Cardiovasc Pharmacol; 1982 Feb 01; 4 Suppl 2():S206-12. PubMed ID: 6177958
    [Abstract] [Full Text] [Related]

  • 33. Plasma lipids and hypertension: response to calcium supplementation.
    Karanja N, Morris CD, Illingworth DR, McCarron DA.
    Am J Clin Nutr; 1987 Jan 01; 45(1):60-5. PubMed ID: 3799505
    [Abstract] [Full Text] [Related]

  • 34. Double-blind comparison of the effects of long-term treatment with doxazosin or atenolol on serum lipoproteins.
    Lehtonen A, Himanen P, Saraste M, Niittymäki K, Marniemi J.
    Br J Clin Pharmacol; 1986 Jan 01; 21 Suppl 1(Suppl 1):77S-81S. PubMed ID: 2939871
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Antihypertensive therapy and modification of metabolic risk factors (glucose and lipid metabolism)].
    Klein W.
    Z Kardiol; 1992 Jun 01; 81(6):295-302. PubMed ID: 1353932
    [Abstract] [Full Text] [Related]

  • 40. Abnormalities of carbohydrate and lipid metabolism in patients with hypertension.
    Fuh MM, Shieh SM, Wu DA, Chen YD, Reaven GM.
    Arch Intern Med; 1987 Jun 01; 147(6):1035-8. PubMed ID: 3296980
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.